Search clinical trials for: Empaglifozin placebo Linagliptin placebo
Total 53465 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
University Hospital, Gentofte, CopenhagenEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
University Medical Centre LjubljanaUnknownDiabetes Complications | Diabetes Mellitus, Type 1 | Vascular Stiffness | Hypoglycemic AgentsSlovenia
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
EMSNot yet recruiting
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
University of PennsylvaniaRecruitingHeart Failure With Preserved Ejection FractionUnited States
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
University Hospital, Gentofte, CopenhagenCompletedDiabetes After Total PancreatectomyDenmark
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Northwell HealthWithdrawnDiabetes | SGLT-2 Inhibitors | Advanced Glycation End Products
-
Boehringer IngelheimActive, not recruitingDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedKidney Disease, ChronicUnited States, Spain, Korea, Republic of, Belgium, Australia, Hong Kong, India, Canada, China, Germany, Italy, Japan, Malaysia, Finland, Switzerland, Turkey, Hungary, Poland, Portugal, Philippines, Czechia, Greece, Bulgaria, Brazil, Arg... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
University Hospital Inselspital, BerneFresenius KabiCompletedMalnourishment | Gastrointestinal TumorsSwitzerland
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedNon-alcoholic Fatty Liver DiseaseHong Kong
-
Merck Sharp & Dohme LLCCompleted
-
Miulli General HospitalNot yet recruitingHeart Failure | Obesity | Diabetes Mellitus | Atrial FibrillationItaly
-
Alexandria UniversityRecruiting
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Saint Luke's Health SystemCompletedHeart FailureUnited States
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Medanta, The Medicity, IndiaNot yet recruitingEmpagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus (EmLina Renal)Diabetes Mellitus | Kidney Transplant; Complications
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Boehringer IngelheimEli Lilly and CompanyCompleted